Week 5- Pulmonary Vascular Disease Flashcards
Define plasma and serum
Plasma: the cell-free fluid of blood with clotting factors intact
Serum: the cell-free fluid of blood with the clotting factors removed (used for most blood tests, except clotting assays)

Define hemostasis and Virchow’s triad of normal hemostasis
mechanism that ensures that blood stays within the vascular system.

How does clotting happen?
Primary clotting
- epithelial injury results in activation, adhesion and aggregation of platelets at the site of injury forming a platelet plug
Secondary clotting
- the clotting cascade results thrombin activation, and in fibrin reinforcing the platelet plug
Describe the clotting cascade in basic terms (initiator, major players)
Extrinsic pathway:
- tissue factor from damaged tissue initiates
- occurs at plateley membrane
Intrinsic pathway
- activated by surface contact with the damaged vessel.
Common pathway
- Converge on factor Xa
- Both result in prothrombin–>thrombin (factor IIa), fibrinogen–> fibrin

What is the timeline for clotting after vascular injury?
The cascade happens in about 30 seconds, and then the extrinsic pathway is inhibited
How is fibrinogen activated?
How is fibrin strengthened?
- Fibrinogen (soluble) is cleaved by thrombin into a fibrin monomer which dimerizes and the polymerizes (insoluble)
- Factor XIIIa crosslinks fibrin polymers
What is the role of vitamin K in clotting?
Vitamin K is required to carboxylate some clotting factors (Glu–>Gla). This modification is necessary to allow the factor to bind calcium, and the calcium is necessary to target the factor to the platelet membrane
How do coumarol drugs work?
How does heparin work?
Coumarol drugs inhibit reduction of vitamin K in the liver, thereby stopping the gamma carboxylation of clotting factors, and making them ineffective (inactivatable).
Heparin accelarates antithrombin activity.
How is clotting terminated ?
- antithrombin gets trapped in the clot
- thrombin will bind thrombomodulin (on endothelial cell membranes) and together activate protein C and protein S, which inactivate the clotting factors found on platelet cell surface. This inactivates prothrombin–> thrombin.
- Tissue factor pathway inhibitor (TFPI)
- activated clotting factors that flow past the site of injury are degraded by proteases in the blood so that the clot stays local
How is a clot degraded (fibrionolysis) after clotting has stopped?
- plasminogen (a plasma protein) is activated by somthing (e.g. urokinase, tPA)
- It cleaves fibrin and produces D-dimer (AKA D2E fragments)
What is prothrombin time? How is it measured? AKA?
- prothrombin time is measured by taking plasma and incubating with thromboplastin (contains tissue factor) and timing how long it takes to clot.
- Measured extrinsic and common pathways
- Given as an **international normalized ratio (INR) **
- Normal is 1, on coumarol INR >1
What is activated partial thromboplastin time (PTT)? How is it measured? What does it measure?
- plasma is incubated with kaolin (clay..) and thromboplastin but no tissue factor and time to clotting is measured
- measures intrinsic and common pathways
What is the classification of thrombotic disease
- Venous thromboembolism
- Arterial thrombosis (usually associated with atherosclerosis)
- Capillary thrombosis (usually associated with hemolytic anemias)
What are the different kind of venous thromboembolism disease?
- superficial vein thrombosis (SVT) (from IV, catheters, etc..)
- Migratory SVT (sign of malignancy)
- DVT
- DVT complications (PE, post-phlebetic syndrome)
What are the heriditary and acquired risk factors for venous thromboembolic disease?
Acquired (much more common)
- Immobility
- age
- pregnancy
- obesity
- trauma
- surgery
- malignancy
- meds (OCP)
- inflammation
- hyperviscosity
- antiphospholipid syndrome
Hereditary
- Factor V Leiden (more resistant to breakdown) (5% of gen. pop)
- prothrombin mutation
- protein C or S deficiency
- antithrombin-3 deficiency
- increased factor 8
- increased homocysteine
Virchow’s triad for thrombosis and the risk factors that fit under each
stasis
- immobility
- age
- pregnancy
- obesity
vascular injury
- surgery
- trauma
- malignancy
- inflammation
- homocysteine
hypercoagulability
- hereditary thrombophilias
- preganancy
- age
- malignancy
- hyperviscosity
- OCP
How does the coexistance of multiple VTE risk factors actually affect risk of VTE?
Acquired + acquired
Acquired +heriditary
are the most common combinations. They have supra-additive effect (having 2 risk factors more than doubles risk)
What is the common clinical presentation of DVT?
- unilateral leg swelling, painful, red and warm (inflammation…must rule out cellulitis)
What are typical and atypical presentations of PE?
Typical
- SOB, chest pain, hemoptysis
Atypical
- abdo pain, syncope, fever, cough, seizures
What is the common clinical presentation of post-phlebitic syndrome? What is the pathophysiology? What is the treatment?
- swelling, pain, ulcers, rash (the ulcers and rash because it is a more chronic thing than DVT)
- this happens because of valve damage/vavular insufficiency after a DVT
- compression stockings
Which tests can you do for DVT?
Radiologic
- ultrasonography: better for proximal DVTs
- spiral CT
Less common radiologic
- V/Q scan (high radiation)
- angiography (invasive)
D-dimer levels
What’s the specificty and sensitivity of D-dimer for DVT?
High sensitivity
Low specificity
When would you do etiologic testing for DVT? What would you test?
In unprovoked and/or recurrent and/or positive family history. BUT inherited thrombophilia unlikely to change treatment.
Test for:
- antithrombin-3
- protein C and protein S
- prothrombin gene mutation
- acquired causes: lupus inhibitor, antiphospholipid antibodies
What is the treatment for DVT?
heparin and coumadin with 5 days overlap, then on coumadin for 6 months
